Efficacy of HUMIRA in Subjects With Active Rheumatoid Arthritis
Phase 4
Completed
- Conditions
- Rheumatoid Arthritis
- Registration Number
- NCT00234897
- Lead Sponsor
- Abbott
- Brief Summary
The purpose of the study is to assess the efficacy of adalimumab in subjects with rheumatoid arthritis focusing on subject-reported outcomes and early response to treatment
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 1938
Inclusion Criteria
- Subject was age 18 or older and in good health (Investigator discretion) with a recent stable medical history.
- Subject, based on assessment of investigator, meets the definition of active RA
Exclusion Criteria
- Subject considered by the investigator, for any reason, to be an unsuitable candidate for the study
- Female subject who is pregnant or breast-feeding or considering becoming pregnant
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Patient reported outcomes, clinical response indicators.
- Secondary Outcome Measures
Name Time Method Subject reported assessments of disease activity, physician reported assessments of disease activity, safety parameters, clinical response indicators.
Trial Locations
- Locations (1)
Global Medical Information - Abbott
🇺🇸North Chicago, Illinois, United States